Self-reported symptoms and medication side effects influence adherence to highly active antiretroviral therapy in persons with HIV infection

Journal of Acquired Immune Deficiency Syndromes

Volumn 28, Issue 5, 2001, Pages 445-449

  Ammassari, Adriana ^a   Murri, Rita ^a   Pezzotti, Patrizio ^b   Trotta, Maria Paola ^c   Ravasio, Laura ^d   De Longis, Patrizio ^c   Caputo, Sergio Lo ^e   Narciso, Pasquale ^c   Pauluzzi, Sergio ^f   Carosi, Giampiero ^g   Nappa, Salvatore ^h   Piano, Paola ⁱ   Izzo, Crescenzo M ^j   Lichtner, Miriam ^k   Rezza, Giovanni ^b   Monforte, Antonella D'Arminio ^d   Ippolito, Giuseppe ^c   Moroni, Mauro ^d   Wu, Albert W ^l   Antinori, Andrea ^c  

^a CATHOLIC UNIVERSITY   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^f UNIVERSITY OF PERUGIA   (Italy)

^g UNIVERSITY OF BRESCIA   (Italy)

^h UNIVERSITY OF NAPLES FEDERICO II   (Italy)

ⁱ UNIVERSITY OF CAGLIARI   (Italy)

^j Azienda Ospedaliera di Rilievo Nazionale D Cotugno   (Italy)

^k SAPIENZA UNIVERSITY OF ROME   (Italy)

^l JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

Adherence; AIDS; HAART; HIV; Medication side effects; Symptoms

Indexed keywords

ANTIRETROVIRUS AGENT;

ANOREXIA; ANXIETY NEUROSIS; ARTICLE; CONFUSION; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INSOMNIA; ITALY; LIPID STORAGE; MAJOR CLINICAL STUDY; NAUSEA; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SCORING SYSTEM; SELF REPORT; STATISTICAL ANALYSIS; SYMPTOMATOLOGY; TASTE DISORDER; UNEMPLOYMENT; VISUAL DISORDER;

EID: 0035894169     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-200112150-00006     Document Type: Article

References (16)

1. The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response
2. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection
3. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
4. Management of the adverse effects of antiretroviral therapy and medication adherence
5. Highly active antiretroviral therapy in a large urban clinic: Risk factors for virologic failure and adverse drug reactions
6. Incidence of adverse reactions in HIV patients treated with protease inhibitors: A cohort study
7. Predictors of self-reported adherence in persons living with HIV disease
8. Patient-reported non-adherence to HAART is related to protease inhibitor levels
9. An index of symptoms for infection with human immunodeficiency virus: Reliability and validity
10. A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection
11. Why is active antiretroviral therapy (HAART) not prescribed or discontinued? Swiss HIV Cohort Study
12. Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral-naive patients
13. Sociodemographic and psychologic variables influencing adherence to antiretroviral therapy
14. Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens
15. Sensitivity, specificity, reliability, and clinical validity of provider-reported symptoms: A comparison with self-reported symptoms
16. Provider assessment of adherence to HIV antiretroviral therapy